跳至主要内容
临床试验/CTRI/2024/03/064552
CTRI/2024/03/064552尚未招募3 期

Characterization of gut dysbiosis in Gastrointestinal Malignancies and exploration of probiotics supplementation on therapeutic outcome in patients receiving chemoradiation in these malignancies. - NI

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Biopsy proven cases of inoperable cases of carcinoma esophagus in which definitive chemoradiation is planned.
  • 2. Biopsy proven cases of carcinoma colon.
  • 3. Patient who have completed radical surgery in the form of hemi colectomy.
  • 4. Patient in whom adjuvant chemotherapy is planned.
  • 5. Biopsy proven cases of carcinoma rectum in which neoadjuvant chemoradiation is planned before definitive surgery.
  • 6. Biopsy proven cases of carcinoma anal canal in which definitive chemoradiation is planned.
  • 7. Karnofsky Performance Status KPS greater than 60 percent.

排除标准

  • 1. Patients who refuse to give their consent.
  • 2. Serious co morbid diseases.
  • 3. Post op patients.
  • 4. History of any prior cancer, or coexisting tumours.
  • 5. Patients with Immunity diseases Autoimmunity or Immunodeficiency.
  • 6. Prior GI toxicities
  • 7. Prior history of radiotherapy administration.
  • 8. Prior probiotics or oral antibiotics intake within 15 days.
  • 9. Metastatic disease.

研究者

相似试验